ASO Author Reflections: Preoperative Chemotherapy Provides Survival Benefits Compared with Upfront Surgery for Patients with Liver-Limited Metastasis from Gastric Cancer

Ann Surg Oncol. 2024 Jun;31(6):4052-4053. doi: 10.1245/s10434-024-15270-4. Epub 2024 Apr 9.

Authors

Affiliations

¹ Department of Digestive Surgery, Niigata Cancer Center Hospital, Niigata, Japan. y-hirose@med.niigata-u.ac.jp.
² Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. y-hirose@med.niigata-u.ac.jp.
³ Department of Digestive Surgery, Niigata Cancer Center Hospital, Niigata, Japan.
⁴ Department of Pathology, Niigata Cancer Center Hospital, Niigata, Japan.

PMID: 38594577
DOI: 10.1245/s10434-024-15270-4

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Chemotherapy, Adjuvant
Hepatectomy / mortality
Humans
Liver Neoplasms* / drug therapy
Liver Neoplasms* / mortality
Liver Neoplasms* / secondary
Liver Neoplasms* / surgery
Neoadjuvant Therapy
Preoperative Care
Prognosis
Stomach Neoplasms* / drug therapy
Stomach Neoplasms* / mortality
Stomach Neoplasms* / pathology
Stomach Neoplasms* / surgery
Survival Rate